
产品完善度:
更新时间:2026/10/9 10:52:01关注度:4748
关键词标签:同分异构体手性柱,Chirex,00G-3126-E0,00G-3022-E0
支付方式:
产品简介
手性分离对制药和生物技术行业以及其它天然产物化学的发展越来越重要。光学活性治疗药物需要有选择性和灵敏的技术。政府法规也继续促使和要求开发出快速、准确和重现的方法分析和纯化手性化合物
Chirex 3126 (D)-Penicillamine详细介绍:
1、高手性选择性
2、快速运行时间
3、耐用,柱寿命长
4、容易放大至制备
5、可以直接/间接分离手性胺、氨基酸、羟基酸、醇、羧酸、酮、醚和酯。
货号 品牌 固定相 粒径 (µm) 孔径 (Å) 长度 (mm) 内径 (mm) 00B-3001-E0 Chirex 3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid 5 120 50 4.6 00B-3005-E0 Chirex 3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid 5 120 50 4.6 00B-3010-E0 Chirex 3010 (S)-valine and 3,5-dinitroaniline 5 120 50 4.6 00B-3011-E0 Chirex 3011 (S)-tert-leucine and 3,5-dinitroaniline 5 120 50 4.6 00B-3012-E0 Chirex 3012 (R)-phenylglycine and 3,5-dinitroaniline 5 120 50 4.6 00B-3014-E0 Chirex 3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine 5 120 50 4.6 00B-3018-E0 Chirex 3018 (S)-proline and (R)-1-(alpha-naphthyl)ethylamine 5 120 50 4.6 00B-3020-E0 Chirex 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine 5 120 50 4.6 00B-3022-E0 Chirex 3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine 5 120 50 4.6 00B-3126-E0 Chirex 3126 (D)-penicillamine 5 110 50 4.6 00F-3001-E0 Chirex 3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid 5 120 150 4.6 00F-3005-E0 Chirex 3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid 5 120 150 4.6 00F-3010-E0 Chirex 3010 (S)-valine and 3,5-dinitroaniline 5 120 150 4.6 00F-3011-E0 Chirex 3011 (S)-tert-leucine and 3,5-dinitroaniline 5 120 150 4.6 00F-3012-E0 Chirex 3012 (R)-phenylglycine and 3,5-dinitroaniline 5 120 150 4.6 00F-3020-B0 Chirex 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine 5 120 150 2 00F-3020-E0 Chirex 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine 5 120 150 4.6 00F-3022-E0 Chirex 3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine 5 120 150 4.6 00F-3126-B0 Chirex 3126 (D)-penicillamine 5 110 150 2 00F-3126-E0 Chirex 3126 (D)-penicillamine 5 110 150 4.6 00F-3126-N0 Chirex 3126 (D)-penicillamine 5 110 150 10 00G-3001-B0 Chirex 3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid 5 120 250 2 00G-3001-E0 Chirex 3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid 5 120 250 4.6 00G-3005-B0 Chirex 3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid 5 120 250 2 00G-3005-E0 Chirex 3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid 5 120 250 4.6 00G-3010-E0 Chirex 3010 (S)-valine and 3,5-dinitroaniline 5 120 250 4.6 00G-3010-N0 Chirex 3010 (S)-valine and 3,5-dinitroaniline 5 120 250 10 00G-3010-P0 Chirex 3010 (S)-valine and 3,5-dinitroaniline 5 120 250 21.2 00G-3011-E0 Chirex 3011 (S)-tert-leucine and 3,5-dinitroaniline 5 120 250 4.6 00G-3012-E0 Chirex 3012 (R)-phenylglycine and 3,5-dinitroaniline 5 120 250 4.6 00G-3012-N0 Chirex 3012 (R)-phenylglycine and 3,5-dinitroaniline 5 120 250 10 00G-3014-E0 Chirex 3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine 5 120 250 4.6 00G-3014-N0 Chirex 3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine 5 120 250 10 00G-3014-P0 Chirex 3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine 5 120 250 21.2 00G-3018-E0 Chirex 3018 (S)-proline and (R)-1-(alpha-naphthyl)ethylamine 5 120 250 4.6 00G-3019-E0 Chirex 3019 (S)-tert-leucine and (S)-1-(alpha-naphthyl)ethylamine 5 120 250 4.6 00G-3019-P0 Chirex 3019 (S)-tert-leucine and (S)-1-(alpha-naphthyl)ethylamine 5 120 250 21.2 00G-3020-D0 Chirex 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine 5 120 250 4 00G-3020-E0 Chirex 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine 5 120 250 4.6 00G-3020-P0 Chirex 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine 5 120 250 21.2 00G-3022-D0 Chirex 3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine 5 120 250 4 00G-3022-E0 Chirex 3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine 5 120 250 4.6 00G-3126-B0 Chirex 3126 (D)-penicillamine 5 110 250 2 00G-3126-E0 Chirex 3126 (D)-penicillamine 5 110 250 4.6 03A-3001-E0 Chirex 3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid 5 120 30 4.6 03A-3005-B0 Chirex 3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid 5 120 30 2 03A-3005-E0 Chirex 3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid 5 120 30 4.6 03A-3010-E0 Chirex 3010 (S)-valine and 3,5-dinitroaniline 5 120 30 4.6 03A-3011-E0 Chirex 3011 (S)-tert-leucine and 3,5-dinitroaniline 5 120 30 4.6 03A-3012-E0 Chirex 3012 (R)-phenylglycine and 3,5-dinitroaniline 5 120 30 4.6 03A-3014-E0 Chirex 3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine 5 120 30 4.6 03A-3018-E0 Chirex 3018 (S)-proline and (R)-1-(alpha-naphthyl)ethylamine 5 120 30 4.6 03A-3019-E0 Chirex 3019 (S)-tert-leucine and (S)-1-(alpha-naphthyl)ethylamine 5 120 30 4.6 03A-3020-E0 Chirex 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine 5 120 30 4.6 03A-3022-D0 Chirex 3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine 5 120 30 4 03A-3022-E0 Chirex 3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine 5 120 30 4.6 03A-3126-E0 Chirex 3126 (D)-penicillamine 5 110 30 4.6